Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Expands By 15.8%

ASP Isotopes Inc. (NASDAQ:ASPI) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 6,450,000 shares, an increase of 15.8% from the November 15th total of 5,570,000 shares. Based on an average daily trading volume, of 4,620,000 shares, the days-to-cover ratio is currently 1.4 days. Currently, 14.1% of the company’s shares are short sold.

Analysts Set New Price Targets

A number of research firms have commented on ASPI. Canaccord Genuity Group restated a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group assumed coverage on ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 target price for the company.

ASP Isotopes Stock Performance

ASPI opened at $5.00 on Monday. The company has a market cap of $356.95 million, a price-to-earnings ratio of -8.20 and a beta of 3.27. The company’s fifty day moving average price is $5.62 and its two-hundred day moving average price is $3.90. ASP Isotopes has a 1-year low of $1.65 and a 1-year high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

Hedge Funds Weigh In On ASP Isotopes

Several large investors have recently added to or reduced their stakes in ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in ASP Isotopes during the 3rd quarter worth approximately $6,249,000. Telemark Asset Management LLC bought a new stake in ASP Isotopes during the third quarter worth $4,726,000. Geode Capital Management LLC raised its position in ASP Isotopes by 42.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after buying an additional 334,836 shares during the last quarter. Vanguard Group Inc. lifted its stake in ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares in the last quarter. Finally, Philadelphia Financial Management of San Francisco LLC boosted its holdings in ASP Isotopes by 158.3% during the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after acquiring an additional 607,893 shares during the last quarter. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.